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,\bstract Thorough analysis of multhner composition and mo- 
lecular structure of recombinant von Willebrand factor (r-vWF) 
produced by recombinant CHO cells demonstrated r-vWF to be 
more intact and less proteolytically degraded than plasma-derived 
v WF (pd-vWF) [B. Fischer et al. (1994) FEBS Lett. 351, 345 
-3481. In contrast to pd-vWF, r-vWF preparations consisted of 
pro-vWF (vWF containing covalently attached propeptide) as 
well as mature vWF subunits forming homo- and hetero-multi- 
mers. In order to ensure complete propeptide processing, a r- 
v WF-producing CHO cell clone was transfected with the cDNA 
of the human propeptide processing enzyme Furin. A r-vWF/r- 
Furin co-expressing cell clone was cultivated at industrial scale 
in high cell density perfusion fermenters. r-vWF obtained from 
these cells was fully processed. Analysis of r-vWF by multlmer 
analysis revealed a multhner pattern equal in number of high 
molecular weight multimer to pd-vWF, but absence of satellite 
hands. Two-dimensional electrophoretic analysis of both the 
primary dimer and the complete multimer pattern of r-vWF 
showed that the recombinant coagulation factor was composed 
exclusively of intact and mature subunits. Since the triplet struc- 
ture typical to pd-vWF is known to reflect proteolytic degrada- 
tion, r-vWF thus exhibits an integrity far superior compared to 
pd-VW. 
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:. Introduction 
The adhesive protein von Willebrand factor exists in human 
l’lasma as a series of heterogeneous homo-multimers ranging 
in size from about 450 kDa to more than 10,000 kDa [14]. The 
lnecursor polypeptide produced in endothelial cells, pre-pro- 
- WF, consists of a 22-residue signal peptide, a 741-residue 
ilro-peptide and the 2050-residue polypeptide found in mature 
ijlasma vWF. After removal of the signal peptide, the resulting 
1 bra-vWF subunits are engaged in a complex biosynthetic proc- 
ss thought to begin with the formation of a primary dimer, 
G ontaining two pro-vWF subunits, through disulphide bond 
‘mkage. Then protomeric units of the multimeric series are 
,rssembled into higher order multimers by disulphide bonding 
1 )f dimers. vWF pro-peptide is cleaved from multimeric vWF 
before release from intracellular storage sites into circulation 
11,3,5,6]. In human plasma vWF serves as a carrier for coagula- 
I ion factor VIII and is required for adhesion of platelets to the 
~ndothelium of injured vessel walls. 
‘Corresponding author. Fax: (43) 2212 2716. 
Plasma concentrates containing vWF are used in the therapy 
of patients with von Willebrand disease unresponsive to the 
nontransfusional agent desmopressin. However, therapeutic 
plasma concentrates containing vWF (i) lack the largest, most 
hemostatically active multimers, and (ii) exhibit various degree 
of degradation of vWF [7]. Apparently, the structural damage 
to plasma-derived vWF is caused by soluble and plateletslleu- 
cocytes associated proteases and occurs at early stages of the 
manufacturing process of plasma concentrates [7]. Changing 
qualities of donor blood and different preparation strategies 
make it even more complicate to produce plasma-derived vWF 
of equal high quality from batch to bath. However, these prob- 
lems may be solved by production of recombinant vWF (r- 
vWF) by fermentation of recombinant cells on an industrial 
scale. 
In a previous investigation, wild-type vWF full-length cDNA 
was expressed in CHO cells (cell clone # 808). Recombinant 
vWF (r-vWFB08) was obtained and its molecular structure was 
investigated to characterize the polypeptide composition of 
r-vWF [8]. Results demonstrated r-vWF/808 to be less prote- 
olytically degraded than pd-vWF, but to contain significant 
amounts of pro-vWF subunits. Analysis of the primary dimer 
of r-vWF/808 identified homo-dimers of either two pro-vWF 
subunits or two mature vWF subunits, as well as hetero-dimers 
of pro-vWF and mature vWF subunits. 
Here, r-vWF-producing CHO cells were additionally manip- 
ulated to co-express the recombinant subtilisinlike proprotein 
processing enzyme Furin (r-Furin) [9,10] in order to ensure 
complete processing of pro-vWF. Recombinant CHO cells (cell 
clone # 904) were cultivated for the first time on an industrial 
scale in high cell density perfusion bio-reactors. Multimer com- 
position and molecular structure of r-vWF/904 produced from 
r-vWF/r-Furin cells were investigated. 
2. Materials and methods 
2. I, Materials 
Seakem Agarose HGT(P) and Gel Bond Film were purchased from 
FMC BioProducts. Acrylamide, N,N’-methylene-bis-acrylamide, so- 
dium dodecyl sulfate (SDS), glycine, ammonium persulfate and alkaline 
phosphatase coloration chemicals were from Bio-Rad Laboratories. 
Normal plasma was from Immuno AG. Rabbit anti-human vWF 
polyclonal antibody and alkaline phosphatase conjugated anti-rabbit 
polyclonal antibody were from Dakopatts. Alkaline phosphatase con- 
jugated affinity purified goat anti rabbit IgG (H + L) was obtained 
from Axe11 Accurate Chemical. Enzyme-linked immunoadsorbent 
assay for vWF was from Boehringer Mannheim. Cytoline 2 microcarri- 
ers were from Pharmacia. All other reagents were purchased from 
Sigma. 
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2.2. Expression of recombinant van Willebrand factor 
Establishment of r-vWF-producing CHO cell clone # 808 was de- 
scribed previously [8]. By transfection with an expression vector encod- 
ing the human Furin cDNA [l l] these cells were additionally manipu- 
lated to over express recombinant Furin, yielding cell clone # 904 
producing r-vWF/904. For scale up production, doubly transformed 
CHO cells were cultivated on an industrial scale in high cell density 
perfusion bio-reactors [12]. Cytoline microcarriers were used for the 
culture of transformed CHO cells in 40 liter bio-reactors. 
2.3. SDS-agarose gel electrophoresis 
SDS-agarose gel electrophoresis was performed in a horizontal elec- 
trophoresis system modified according to Ruggeri and Zimmermann 
[2] using low resolution 1% agarose gels and high resolution 2% agarose 
gels. Visualization of vWF multimers was carried out by immunoenzy- 
matic staining modified according to Aihara et al. [13]. As primary 
antibody a rabbit anti human von Willebrand factor anti serum was 
used in a dilution of I : 5000. As a secondary antibody alkaline phos- 
phatase conjugated affinity purified goat anti rabbit IgG was used in 
a dilution of 1: 1000. Staining was performed with the nitroblue tetra- 
zolium chloride/bromochloro indolyl phosphate substrate system. 
2.4. Two-dimensional SDS-electrophoresis 
High resolution two-dimensional SDS-electrophoresis of vWF pri- 
mary dimer was performed by combination of non-reducing high-reso- 
lution SDS-polyacrylamide/agarose gel for the first dimension and re- 
ducing SDS-polyacrylamide gel for the second dimension. Preparation 
of first dimension non-reducing SDS-3% polyacrylamide/OS% agarose 
gels with 5% crosslinking and sample preparation have been described 
in detail previously [8]. For resolution in the second dimension, 5% 
acrylamide SDS-polyacrylamide gels under reducing conditions were 
prepared [8]. Two-dimensional SDS-electrophoresis of vWF multimers 
was performed by combination of non-reducing low-resolution SDS- 
1% agarose gel for the first dimension and reducing SDS-5% poly- 
acrylamide gel for the second dimension. 
2.5. Immunoblotting 
Polypeptides resolved by electrophoresis were transferred onto nitro- 
cellulose membranes in 25 mM Tris, 192 mM glycine, 20% (vol/vol) 
methanol buffer [14]. Detection of vWF by rabbit anti-human vWF 
immunoglobulins and staining by alkaline phosphatase conjugated 
goat anti-rabbit antibodies has been described previously [8]. 
3. Results and discussion 
Preparation of plasma-derived vWF for therapy of patients 
with von Willebrand disease is limited due to lack the largest, 
most hemostatically active multimers, and proteolytic degrada- 
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Fig. 1. SDS-agarose gel electrophoresis of von Willebrand factor at 
non-reducing conditions. (A) Low resolution 1% agarose gel electro- 
phoresis. (B) High resolution 2% agarose gel electrophoresis. (a) pd- 
vWF, (b) r-vWF/904, (c) r-vWF1808. 
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Fig. 2. Multimer analysis of r-vWF/904 during adaptation of recombi- 
nant CHO cells to serum-free medium. (A) r-vWF/904 produced at day 
18 in fermentation medium containing 2.5% serum; (B) r-vWF/904 
produced at day 24 during adaptation to serum free medium; 
(C) r-vWF/904 produced at day 29 during adaptation to serum free 
medium; (D) r-vWF1904 produced at day 35 in serum-free medium; 
(E) r-vWF/904 produced at day 44 in serum-free medium; (F) r-vWF/ 
904 produced at day 51 in serum-free medium; (G) r-vWF/904 pro- 
duced at day 56 in serum free medium; (H) r-vWF/904 produced at day 
65 in serum-free medium. 
tion of vWF during plasma fractionation [7]. An alternative to 
plasma-derived protein may be the production of recombinant 
vWF. 
In a previous investigation structural properties of r-vWF/ 
808 produced by recombinant CHO cells have been described 
[8]. Due to incomplete processing, r-vWF/808 contained signif- 
icant amounts of pro-vWF thus forming homo- and hetero- 
polymers. Here we present structural data on r-vWF/904 pro- 
duced on an industrial scale by recombinant CHO cells secret- 
ing both recombinant vWF and recombinant propeptidase 
Furin. To ensure complete processing, r-vWF-producing CHO- 
cells (cell clone # 808; producing r-vWF1808) were additionally 
manipulated to co-express the recombinant propeptidase 
Furin, resulting in CHO-cell clone # 904, producing r-vWF/ 
904. Fig. 1 compares the multimer structures of r-vWF/808, 
r-vWF/904 and pd-vWF, at low resolution 1% agarose gel elec- 
trophoresis (Fig. 1A) and high resolution 2% agarose gel elec- 
trophoresis (Fig. 1B). Both pd-vWF, r-vWF/808 and r-vWF/ 
904 exhibited a similar multimer pattern. However, individual 
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F g. 3. Two-dimensional analysis of the primary dimer of r-vWF/904. 
r gWF1904 was separated in the first dimension by non-reducing high 
rl solution SDS-3% acrylamide/0.5% agarose gel electrophoresis. Indi- 
v dual gel lanes containing the primary dimer vWF-related proteins 
M :re cut out, incubated in reducing buffer, mounted on top of a 5% 
a~ rylamide gel, and electrophoresed in the second dimension (B). Si- 
n ultaneously, denatured-reduced r-vWF1904 (C), and prestained refer- 
e ice proteins (A) were analysed. 
I? ultimers of r-vWF1904 appear to be more compact than to 
pi-vWF and r-vWFL308 multimers. Individual pd-vWF mul- 
t mers are surrounded by diffuse satellite bands of slightly in- 
c .eased as well as reduced molecular weights, forming a triplet 
sructure typical to pd-vWF. The satellite bands have been 
iclentified as proteolytic degradation products of vWF in 
f.asma [15-171. Protease cleavage sites have been localized in 
pJ-vWF [18]. By contrast, satellite bands are missing both in 
r vWF/808 and r-vWF/904 (Fig. 1). A somewhat broader pic- 
t u-e of individual multimer bands of r-vWF/808 results from 
t re mixtures of various combinations of mature vWF and pro- 
\ WF subunits forming homo- and hetero-multimers of in- 
c .eased moleculare weight [8]. By contrast, electrophoretic 
a ralysis under reducing conditions showed that of r-vWF/904 
f reduced on an industrial scale fermentation was composed 
e tclusively of mature vWF monomers, explaining the more 
c Impact r-vWF/904 multimer pattern. 
Proteolysis of pd-vWF may also result in loss of the largest, 
r lost hemostatically active cWF multimers [7,17]. However, 
t- oth r-vWF1808 and r-vWF1904 exhibited very high molecular 
v eight multimers absent in pd-vWF (Fig. 1). 
The possibility of reduced concomitant quantities of pro- 
I WF during the expression of r-vWF by co-expressing the 
fropeptidase Furin has been tested so far on an laboratory 
s :ale. In the present investigation double-transformed CHO 
c :lls were cultivated on an industrial scale in high cell density 
Terfusion bio-reactors. During the expression of r-vWF cell 
c:nsity reached levels of 335 x 10’ cells per ml carrier. Stable 
e cpression of r-vWF/904 over a period of several weeks resulted 
i:~ the continuous production of several hundred mg vWF anti- 
g;n per day. Fig. 2 shows the multimer analysis of r-vWF/904 
produced by recombinant CHO cells prior, during and after 
adaptation to serum-free medium. Adaptation to serum-free 
medium did not affect large-size multimers. More than 20 re- 
peats of multimers are observed for r-vWF1904, ruling out 
proteolytic digestion of r-vWF/904. 
The structural composition of the primary dimer of r-vWF/ 
904 was analyzed by high resolution SDS-3% acrylamidelOS% 
agarose gel electrophoresis at non-reducing conditions. The 
results showed that the primary dimer of r-vWF1904 exhibited 
a single protein band of a molecular weight of 450 kDa (Fig. 
3). In contrast, in previous studies r-vWF1808 was separated 
into three protein bands with molecular masses between 450 to 
600 kDa [8], representing homo-dimers of mature vWF sub- 
units, hetero-dimers of mature vWF and pro-vWF subunits and 
homo-dimers of pro-vWF subunits [8]. The primary dimer of 
pd-vWF exhibited a heterogeneous mixture of protein bands 
with apparent molecular weights of 150 kDa to 450 kDa, re- 
flecting proteolytic degradation of pd-vWF subunits [8]. To 
analyze the molecular composition of the primary dimer of 
r-vWF1904 in more detail, two-dimensional electrophoresis was 
carried out with non-reducing SDS-polyacrylamidelagarose gel 
electrophoresis in the first dimension and reducing SDS-poly- 
acrylamide gel electrophoresis in the second dimension. High- 
resolution SDS-polyacrylamide/agarose gel electrophoresis of 
r-vWF1904 (Fig. 3) resulted in one protein band labeled lU,. 
(terminology according to [15]) in the first dimension. Second 
dimension electrophoresis showed that this protein band con- 
tained exclusively mature vWF subunits. No proteolytic degra- 
dation products were detected. In contrast, previous structural 
analysis of the primary dimers of r-vWF/808 and pd-vWF the 
detected hetero- as well as homo-dimers and different vWF- 
subunit degradation products, respectively [8]. 
Fig. 4 shows the two-dimensional electrophoretic analysis of 
the complete multimer pattern of r-vWF/904. First dimension 
non-reducing SDS- 1% agarose gel electrophoresis of r-vWF/ 
904 separated all the individual multimers. Second dimension 
SDS-5% acrylamide gel electrophoresis under reducing condi- 
tions showed that all r-vWF/904 multimers were composed 
exclusively of intact mature subunits. Although produced in the 
presence of the protease Furin, r-vWF1904 exhibited no degra- 
1. 
Fig. 4. Two-dimensional analysis of multimer pattern of r-vWF/904. 
r-vWF/ 904 was separated in the first dimension by non-reducing SDS- 
1% agarose gel electrophoresis. An individual gel lane containing the 
multimer pattern was cut out, incubated in reducing buffer, mounted 
on top of a 5% acrylamide gel, and electrophoresed in the second 
dimension (B). Simultaneously, denatured-reduced r-vWF/904 (C), and 
prestained reference proteins (A) were analysed. 
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dation products. Thus, stable expression of recombinant vWF 
in the presence of overexpressed propeptidase Furin, produced 
on an industrial scale, resulted in a completely processed, mat- 
urated vWF, composed of intact subunits forming low and high 
molecular weight multimers. 
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